| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |